Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/51987
Title: Peptide KED: molecular-genetic aspects of neurogenesis regulation in Alzheimer’s disease
Authors: Khavinson, V. Kh.
Linkova, N. S.
Umnov, R. S.
Keywords: medicine
pharmacology
peptide KED
gene expression
neuroprotection
Alzheimer’s disease
Issue Date: 2021
Citation: Khavinson, V.Kh. Peptide KED: molecular-genetic aspects of neurogenesis regulation in Alzheimer’s disease / Khavinson V.Kh., N.S. Linkova, R.S. Umnov // Bulletin of Experimental Biology and Medicine. - 2021. - Vol.171, №2.-P. 190-193.
Abstract: Neuroprotective peptides are promising candidate molecules for the treatment of Alzheimer’s disease (AD). Oral application of KED (Lys-Glu-Asp) improved memory and attention in elderly individuals with functional CNS disorders. Peptide KED also restores synaptic plasticity in in vitro model of AD. This review is focused on the analysis of the influence of KED peptide on the expression of genes and synthesis of proteins regulating apoptosis, aging, neurogenesis, and involved in AD pathogenesis
URI: http://dspace.bsu.edu.ru/handle/123456789/51987
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Linkova_Peptide KED.pdf665.89 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.